These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11874967)
1. Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Näf S; Esmatjes E; Recasens M; Valero A; Halperin I; Levy I; Gomis R Diabetes Care; 2002 Mar; 25(3):634-5. PubMed ID: 11874967 [No Abstract] [Full Text] [Related]
2. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615 [No Abstract] [Full Text] [Related]
3. Severe lipoatrophy with human insulin: successfully treated by CSII. Chantelau E; Reuter M; Schotes S; Starke AA Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099 [No Abstract] [Full Text] [Related]
4. Prolonged desensitization required for treatment of generalized allergy to human insulin. Thompson DM; Ronco JJ Diabetes Care; 1993 Jun; 16(6):957-8. PubMed ID: 8325221 [No Abstract] [Full Text] [Related]
5. Subcutaneous antihistamine injection is effective to control a local allergic reaction to human insulin. Imakado S; Hamada K; Atsumi Y Diabetes Res Clin Pract; 2009 Sep; 85(3):e42-3. PubMed ID: 19520450 [TBL] [Abstract][Full Text] [Related]
7. Generalized allergy due to zinc and protamine in insulin preparation treated with insulin pump. Gin H; Aubertin J Diabetes Care; 1987; 10(6):789-90. PubMed ID: 3322735 [No Abstract] [Full Text] [Related]
8. Insulin-pump therapy: effect of phosphate-buffered human insulin. Ratner RE; Steiner ML Diabetes Care; 1987; 10(6):787-8. PubMed ID: 3322734 [No Abstract] [Full Text] [Related]
9. A case of lipoatrophy with human insulin-therapy. Chantelau E; Reuter M; Schotes S; Starke AA Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992 [TBL] [Abstract][Full Text] [Related]
10. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion. Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054 [TBL] [Abstract][Full Text] [Related]
11. Role of Devices in Insulin Delivery. Meneghini LF; McNulty JN Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052 [No Abstract] [Full Text] [Related]
12. Localized insulin allergy treated with continuous subcutaneous insulin. Pratt EJ; Miles P; Kerr D Diabet Med; 2001 Jun; 18(6):515-6. PubMed ID: 11472474 [No Abstract] [Full Text] [Related]
13. Type III Hypersensitivity Reaction to Subcutaneous Insulin Preparations in a Type 1 Diabetic. Murray BR; Jewell JR; Jackson KJ; Agboola O; Alexander BR; Sharma P J Gen Intern Med; 2017 Jul; 32(7):841-845. PubMed ID: 28337685 [TBL] [Abstract][Full Text] [Related]
14. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Radermecker RP; Scheen AJ Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593 [TBL] [Abstract][Full Text] [Related]
15. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Nagai T; Nagai Y; Tomizawa T; Mori M Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776 [TBL] [Abstract][Full Text] [Related]
16. Human insulin allergy: four case reports. Teixeira Rodrigues A; Ensina LF; Sabino Garro L; Kase Tanno L; Giavina-Bianchi P; Motta AA Eur Ann Allergy Clin Immunol; 2010 Dec; 42(6):221-3. PubMed ID: 21287946 [TBL] [Abstract][Full Text] [Related]
17. Insulin therapy in the last decade. A pediatric perspective. Santiago JV Diabetes Care; 1993 Dec; 16 Suppl 3():143-54. PubMed ID: 8299471 [No Abstract] [Full Text] [Related]
18. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy. Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896 [TBL] [Abstract][Full Text] [Related]